Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2017, Article ID 8392035, 13 pages
https://doi.org/10.1155/2017/8392035
Research Article

Cytotoxicity Study of Cyclopentapeptide Analogues of Marine Natural Product Galaxamide towards Human Breast Cancer Cells

1Department of Chemistry, College of Chemistry and Materials Science, Jinan University, 510632 Guangzhou, China
2Institute of Biomineralization and Lithiasis Research, Jinan University, 510632 Guangzhou, China

Correspondence should be addressed to Bingxin Zhao; moc.361@226048xbz and Shihai Xu; nc.ude.unj@hsuxt

Received 3 June 2017; Revised 18 October 2017; Accepted 26 October 2017; Published 19 December 2017

Academic Editor: Felipe Dal Pizzol

Copyright © 2017 Jignesh Lunagariya et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Reuter, S. C. Gupta, M. M. Chaturvedi, and B. B. Aggarwal, “Oxidative stress, inflammation, and cancer: how are they linked?” Free Radical Biology & Medicine, vol. 49, no. 11, pp. 1603–1616, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Gorrini, I. S. Harris, and T. W. Mak, “Modulation of oxidative stress as an anticancer strategy,” Nature Reviews Drug Discovery, vol. 12, no. 12, pp. 931–947, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Z. Guyton and T. W. Kensler, “Oxidative mechanisms in carcinogenesis,” British Medical Bulletin, vol. 49, no. 3, pp. 523–544, 1993. View at Publisher · View at Google Scholar · View at Scopus
  4. J. E. Klaunig, L. M. Kamendulis, and B. A. Hocevar, “Oxidative stress and oxidative damage in carcinogenesis,” Toxicologic Pathology, vol. 38, no. 1, pp. 96–109, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. J. E. Klaunig, Y. Xu, J. S. Isenberg et al., “The role of oxidative stress in chemical carcinogenesis,” Environmental Health Perspectives, vol. 106, Supplement 1, pp. 289–295, 1998. View at Publisher · View at Google Scholar
  6. C. DeSantis, R. Siegel, P. Bandi, and A. Jemal, “Breast cancer statistics, 2011,” CA: a Cancer Journal for Clinicians, vol. 61, no. 6, pp. 408–418, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. R. L. Siegel, K. D. Miller, and A. Jemal, “Cancer statistics, 2016,” CA: a Cancer Journal for Clinicians, vol. 66, no. 1, pp. 7–30, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. J. T. Ribeiro, L. T. Macedo, G. Curigliano et al., “Cytotoxic drugs for patients with breast cancer in the era of targeted treatment: back to the future?” Annals of Oncology, vol. 23, no. 3, pp. 547–555, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Liu, W. Gu, D. Lo et al., “N-Methylsansalvamide a peptide analogues. Potent new antitumor agents,” Journal of Medicinal Chemistry, vol. 48, no. 10, pp. 3630–3638, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. T. J. Styers, A. Kekec, R. Rodriguez et al., “Synthesis of sansalvamide a derivatives and their cytotoxicity in the colon cancer cell line HT-29,” Bioorganic & Medicinal Chemistry, vol. 14, no. 16, pp. 5625–5631, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. R. A. Rodriguez, P.-S. Pan, C.-M. Pan et al., “Synthesis of second-generation sansalvamide a derivatives: novel templates as potential antitumor agents,” The Journal of Organic Chemistry, vol. 72, no. 6, pp. 1980–2002, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. P. S. Pan, K. L. McGuire, and S. R. McAlpine, “Identification of sansalvamide a analog potent against pancreatic cancer cell lines,” Bioorganic & Medicinal Chemistry Letters, vol. 17, no. 18, pp. 5072–5077, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Liu, X. Zhao, L. Xiao et al., “Induction of apoptosis, G0/G1 phase arrest and microtubule disassembly in K562 leukemia cells by Mere15, a novel polypeptide from Meretrix meretrix Linnaeus,” Marine Drugs, vol. 10, no. 12, pp. 2596–2607, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. T. D. Tran, N. B. Pham, G. A. Fechner, J. N. A. Hooper, and R. J. Quinn, “Potent cytotoxic peptides from the Australian marine sponge Pipestela candelabra,” Marine Drugs, vol. 12, no. 6, pp. 3399–3415, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. K.-X. Zhan, W.-H. Jiao, F. Yang et al., “Reniochalistatins A–E cyclic peptides from the marine sponge Reniochalina stalagmitis,” Journal of Natural Products, vol. 77, no. 12, pp. 2678–2684, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. A. K. Mukherjee, A. J. Saviola, P. D. Burns, and S. P. Mackessy, “Apoptosis induction in human breast cancer (MCF-7) cells by a novel venom L-amino acid oxidase (rusvinoxidase) is independent of its enzymatic activity and is accompanied by caspase-7 activation and reactive oxygen species production,” Apoptosis, vol. 20, no. 10, pp. 1358–1372, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. X. W-J, X.-J. Liao, X. S-H et al., “Isolation, structure determination, and synthesis of galaxamide, a rare cytotoxic cyclic pentapeptide from a marine algae Galaxaura filamentosa,” Organic Letters, vol. 10, no. 20, pp. 4569–4572, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. X. Xiao, X. Liao, S. Qui, Z. Liu, B. Du, and S. Xu, “Paper synthesis cytotoxicity and apoptosis induction in human tumor cells by galaxamide and its analogues,” Marine Drugs, vol. 12, no. 8, pp. 4521–4538, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Lunagariya, S. Zhong, J. Chen et al., “Design and synthesis of analogues of marine natural product galaxamide, an N-methylated cyclic pentapeptide, as potential anti-tumor agent in vitro,” Marine Drugs, vol. 14, no. 9, p. 161, 2016. View at Publisher · View at Google Scholar · View at Scopus
  20. I. M. Ghobrial, T. E. Witzig, and A. A. Adjei, “Targeting apoptosis pathways in cancer therapy,” CA: a Cancer Journal for Clinicians, vol. 55, no. 3, pp. 178–194, 2005. View at Google Scholar
  21. I. Budihardjo, H. Oliver, M. Lutter, X. Luo, and X. Wang, “Biochemical pathways of caspase activation during apoptosis,” Annual Review of Cell and Developmental Biology, vol. 15, no. 1, pp. 269–290, 1999. View at Publisher · View at Google Scholar · View at Scopus
  22. J. C. Martinou and R. J. Youle, “Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics,” Developmental Cell, vol. 21, no. 1, pp. 92–101, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Vilema-Enríquez, A. Arroyo, M. Grijalva, R. I. Amador-Zafra, and J. Camacho, “Molecular and cellular effects of hydrogen peroxide on human lung cancer cells: potential therapeutic implications,” Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 1908164, 12 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  24. G.-W. Wang, C. Lv, Z.-R. Shi et al., “Abieslactone induces cell cycle arrest and apoptosis in human hepatocellular carcinomas through the mitochondrial pathway and the generation of reactive oxygen species,” PLoS One, vol. 9, no. 12, article e115151, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. D. Bai, S. Yu, S. Zhong et al., “D-Amino acid position influences the anticancer activity of galaxamide analogs: an apoptotic mechanism study,” International Journal of Molecular Sciences, vol. 18, no. 3, p. 544, 2017. View at Publisher · View at Google Scholar
  26. S. Zhang, T. Govender, T. Norstrom, and P. I. Arvidsson, “An improved synthesis of Fmoc-N-methyl-α-amino acids,” The Journal of Organic Chemistry, vol. 70, no. 17, pp. 6918–6920, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. E. Kaiser, R. L. Colescott, C. D. Bossinger, and P. I. Cook, “Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides,” Analytical Biochemistry, vol. 34, no. 2, pp. 595–598, 1970. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Vojkovsky, “Detection of secondary amines on solid phase,” Peptide Research, vol. 8, no. 4, pp. 236-237, 1995. View at Google Scholar
  29. T. F. Molinski, D. S. Dalisay, S. L. Lievens, and J. P. Saludes, “Drug development from marine natural products,” Nature Reviews Drug Discovery, vol. 8, no. 1, pp. 69–85, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Thundimadathil, “Cancer treatment using peptides: current therapies and future prospects,” Journal of Amino Acids, vol. 2012, Article ID 967347, 13 pages, 2012. View at Publisher · View at Google Scholar
  31. X. X. Zhang, H. S. Eden, and X. Chen, “Peptides in cancer nanomedicine: drug carriers, targeting ligands and protease substrates,” Journal of Controlled Release, vol. 159, no. 1, pp. 2–13, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. V. Ruiz-Torres, J. A. Encinar, M. Herranz-López et al., “An updated review on marine anticancer compounds: the use of virtual screening for the discovery of small-molecule cancer drugs,” Molecules, vol. 22, no. 7, article 1037, 2017. View at Publisher · View at Google Scholar
  33. K. Otrubova, G. Lushington, D. Vander Velde, K. L. McGuire, and S. R. McAlpine, “Comprehensive study of Sansalvamide A derivatives and their structure–activity relationships against drug-resistant colon cancer cell lines,” Journal of Medicinal Chemistry, vol. 51, no. 3, pp. 530–544, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. Fuchs and H. Steller, “Programmed cell death in animal development and disease,” Cell, vol. 147, no. 4, pp. 742–758, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. S. W. Fesik, “Promoting apoptosis as a strategy for cancer drug discovery,” Nature Reviews Cancer, vol. 5, no. 11, pp. 876–885, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. R. Gerl and D. L. Vaux, “Apoptosis in the development and treatment of cancer,” Carcinogenesis, vol. 26, no. 2, pp. 263–270, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. M. B. Ujiki, B. Milam, X.-Z. Ding et al., “A novel peptide sansalvamide analogue inhibits pancreatic cancer cell growth through G0/G1 cell-cycle arrest,” Biochemical and Biophysical Research Communications, vol. 340, no. 4, pp. 1224–1228, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. N. Ahmad, D. K. Feyes, A.-L. Nieminen, R. Agarwal, and H. Mukhtar, “Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells,” JNCI: Journal of the National Cancer Institute, vol. 89, no. 24, pp. 1881–1886, 1997. View at Publisher · View at Google Scholar
  39. X. Grana and E. P. Reddy, “Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs),” Oncogene, vol. 11, no. 2, pp. 211–219, 1995. View at Google Scholar
  40. H. Murad, M. Hawat, A. Ekhtiar et al., “Induction of G1-phase cell cycle arrest and apoptosis pathway in MDA-MB-231 human breast cancer cells by sulfated polysaccharide extracted from Laurencia papillosa,” Cancer Cell International, vol. 16, no. 1, p. 39, 2016. View at Publisher · View at Google Scholar · View at Scopus
  41. C. Sánchez-Martínez, L. M. Gelbert, M. J. Lallena, and A. de Dios, “Cyclin dependent kinase (CDK) inhibitors as anticancer drugs,” Bioorganic & Medicinal Chemistry Letters, vol. 25, no. 17, pp. 3420–3435, 2015. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Gasco, S. Shami, and T. Crook, “The p53 pathway in breast cancer,” Breast Cancer Research, vol. 4, no. 2, pp. 70–76, 2002. View at Publisher · View at Google Scholar · View at Scopus
  43. A. J. Levine, W. Hu, and Z. Feng, “The p53 pathway: what question remain to be explored?” Cell Death & Differentiation, vol. 13, no. 6, pp. 1027–1036, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. N. Noda and H. Wakasugi, “Cancer and oxidative stress,” Journal of the Japan Medical Association, vol. 44, no. 12, pp. 535–539, 2001. View at Google Scholar
  45. X.-Y. Fang, W. Chen, J.-T. Fan et al., “Plant cyclopeptide RA-V kills human breast cancer cells by inducing mitochondria-mediated apoptosis through blocking PDK1–AKT interaction,” Toxicology and Applied Pharmacology, vol. 267, no. 1, pp. 95–103, 2013. View at Publisher · View at Google Scholar · View at Scopus
  46. J. Lopez and S. W. G. Tait, “Mitochondrial apoptosis: killing cancer using the enemy within,” British Journal of Cancer, vol. 112, no. 6, pp. 957–962, 2015. View at Publisher · View at Google Scholar · View at Scopus
  47. I. R. Indran, G. Tufo, S. Pervaiz, and C. Brenner, “Recent advances in apoptosis, mitochondria and drug resistance in cancer cells,” Biochimica et Biophysica Acta (BBA) - Bioenergetics, vol. 1807, no. 6, pp. 735–745, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. N. Zamzami, P. Marchetti, M. Castedo et al., “Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death,” Journal of Experimental Medicine, vol. 182, no. 2, pp. 367–377, 1995. View at Publisher · View at Google Scholar · View at Scopus
  49. H. U. Simon, A. Haj-Yehia, and F. Levi-Schaffer, “Role of reactive oxygen species (ROS) in apoptosis induction,” Apoptosis, vol. 5, no. 5, pp. 415–418, 2000. View at Publisher · View at Google Scholar · View at Scopus
  50. M. Zafarullah, W. Q. Li, J. Sylvester, and M. Ahmad, “Molecular mechanisms of N-acetylcysteine actions,” Cellular and Molecular Life Sciences, vol. 60, no. 1, pp. 6–20, 2003. View at Publisher · View at Google Scholar · View at Scopus
  51. C. Ravi, A. Qayum, D. C. Mohan, S. K. Singh, and S. Adimurthy, “Design, synthesis and cytotoxicity studies of novel pyrazolo[1, 5-a]pyridine derivatives,” European Journal of Medicinal Chemistry, vol. 126, pp. 277–285, 2017. View at Publisher · View at Google Scholar